10480 ViiV Healthcare Company

About ViiV Healthcare

ViiV Healthcare is a global specialist HIV company dedicated to delivering innovative medicines and solutions for people living with HIV. Established in 2009, ViiV is a joint venture between GlaxoSmithKline, Pfizer, and Shionogi, focusing exclusively on HIV treatment and prevention.

With a commitment to advancing the science of HIV, ViiV Healthcare invests heavily in research and development to create effective therapies that improve the quality of life for individuals affected by this virus. The company’s portfolio includes a range of antiretroviral medications that are designed to meet the diverse needs of patients.

ViiV Healthcare is also dedicated to addressing the broader challenges associated with HIV, including stigma and access to care. Through partnerships with healthcare providers, community organisations, and governments, ViiV works to enhance awareness and education about HIV prevention and treatment.

The company’s vision is to achieve a world where people living with HIV can lead long, healthy lives without discrimination. ViiV Healthcare strives to be at the forefront of HIV innovation, ensuring that new treatments are accessible to those who need them most.

In addition to its focus on treatment, ViiV Healthcare is actively involved in initiatives aimed at preventing new HIV infections, particularly among vulnerable populations. The company believes in a holistic approach to healthcare, integrating mental health support and social services into its programmes.

ViiV Healthcare operates globally, with a strong presence in the UK and other key markets. The company is committed to sustainability and ethical practices, ensuring that its operations positively impact communities and the environment.

Through its dedication to research, advocacy, and community engagement, ViiV Healthcare continues to lead the way in transforming the landscape of HIV care and prevention.